Answers are grounded in this paper and cite their sources.
Our comprehensive analysis of prospectively clinically sequenced ECs revealed significant differences in their histologic and molecular composition and in the presence of therapeutic targets in Black versus White patients. These findings emphasize the importance of incorporating diverse populations into molecular studies and clinical trials to address EC disparities. This article is featured in Selected Articles from This Issue, p. 2293.
No takes yet. Share an insight, caveat, or question.
Weigelt et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: